Overzicht EU-wetgeving voor OTC siroopverpakkingen

The regulatory environment has a great impact on business, especially in healthcare. Non-compliance exposes companies to the risk of launch delay, delisting products from the market and out-of-stocks. Moreover, it can cause reputational damage affecting staff, consumer and shareholder confidence, reduce market opportunities, and affect the bottom line. This article, written by Piotr Zaborniak of GlaxoSmithKline (GSK), gives a compact overview of the current regulatory requirements in Europe for Over The Counter (OTC) syrup packaging. It covers subjects like the authorisation process, the Medical Devices Directive, and Directive 2001/83/EC (European Pharmaceutical Review, 21 augustus 2017).
Klik hier om het artikel te lezen.
Klik hier voor meer informatie over het NVC-project Pharmaceutical Packaging Innovation.
Klik hier voor meer informatie over de NVC E-Course Pharmaceutical Packaging.

Dit bericht is ook opgenomen in ons maandelijkse nieuwsoverzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.